Sofosbuvir Tablets (Sovaldi) – 400?mg Low price comparison

Sofosbuvir Tablets (Sovaldi) – 400?mg Low price comparison

$1.00

Sovaldi (sofosbuvir) delivers 400?mg per orange film?coated tablet, 28 tablets per bottle. Manufactured by Gilead Sciences Ireland UC, approved in China under HJ20170365, this potent NS5B polymerase inhibitor is widely used in research on hepatitis C virus replication mechanisms, antiviral screening, and resistance studies.
?? For laboratory and research use only. Not for clinical or diagnostic applications.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

描述

Sofosbuvir is a nucleotide analog prodrug that inhibits the HCV NS5B RNA-dependent RNA polymerase, essential for viral replication Nature+15PMC+15European Medicines Agency (EMA)+15. It is the active component in the brand Sovaldi, characterized by a yellow, film-coated tablet containing 400?mg of sofosbuvir.

This formulation is ideal for preclinical research focusing on viral replication, drug resistance mechanisms, combination therapy models, and biochemical pharmacology involving HCV. Although clinically approved for hepatitis C treatment, this product is supplied for laboratory research and wholesale use.


Sofosbuvir Tablets Product Specifications

Parameter Details
Product Name Sofosbuvir Tablets (Sovaldi)
Generic Name Sofosbuvir
CAS Number 1190307?88?0
Molecular Formula C??H??FN?O?P
Molecular Weight ~529.45?g/mol
Strength 400?mg per tablet
Quantity 28 tablets per bottle
Dosage Form Film?coated oral tablet
Approval Number HJ20170365 (China)
Manufacturer Gilead Sciences Ireland UC
Barcode [Contact for barcode]
Storage Conditions Store ??30?°C; keep in original container
Intended Use Laboratory research: HCV virology, antiviral screening, enzymology

Sofosbuvir Tablets Mechanism of Action

Sofosbuvir is metabolized in hepatocytes to its active triphosphate form, which competitively blocks the HCV NS5B polymerase, causing premature termination of RNA synthesis . This inhibition applies across all major HCV genotypes and has a high barrier to resistance.


Sofosbuvir Tablets Research Applications

  • Viral replication assays targeting NS5B polymerase

  • Resistance profiling for direct-acting antivirals (DAAs)

  • Combination antiviral screening (e.g., sofosbuvir + velpatasvir)

  • Studies of activation/metabolism pathways in hepatocytes

  • Mechanistic research into HCV virology and pharmacodynamics


Safety & Handling

  • Use standard laboratory PPE (lab coat, gloves, eye protection)

  • Conduct all handling in research-grade conditions

  • Store in a sealed container away from heat and moisture

  • Not for human or veterinary clinical use


Core Keywords

sofosbuvir tablets 400mg, Sovaldi, CAS 1190307-88-0, HCV NS5B inhibitor, HCV research compound, nucleotide analog sofosbuvir, antiviral screening drug, Gilead sofosbuvir tablet, hepatitis C lab reagent


Research Use Disclaimer

This product is intended only for laboratory and preclinical research. It is not approved for clinical, diagnostic, therapeutic, or veterinary application. Misuse may result in health or regulatory consequences. Use responsibly following institutional protocols.

其他信息

重量 1 公斤
尺寸 32 × 36 × 32 厘米

评价

目前还没有评价

成为第一个“Sofosbuvir Tablets (Sovaldi) – 400?mg Low price comparison” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

EMI Options

Select at least 2 products
to compare